LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
Clinical trial NCT07391566 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07391566
- Sponsor
- Luye Pharma Group Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2028-12-31
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.